Estrogen and related hormone effects
Moving in JNCI: Journal of the National Cancer Institute, bioRxiv, Clinical Cancer Research, JAMA Internal Medicine, Journal of Clinical Investigation, Nature Aging, Annals of Oncology and Arteriosclerosis, Thrombosis, and Vascular Biology.
- Moved, week to 17 Nov 2026
- 0
- Papers in 60 days
- 31
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Estrogen and related hormone effects
Newest first · last 60 days
AI summary · may contain errors
MHT initiation in perimenopausal or recently postmenopausal women with vasomotor symptoms is linked to lower CVD event risk (aHR 0.78, 95% CI 0.62–0.98) in SWAN.
- 1 cites
AI summary · may contain errors
Intratumoral androstenedione (A4) levels in breast cancer specimens are linked to a 90-gene transcriptional classifier that stratifies patients into low, intermediate, and high A4 groups with different outcomes.
- Open access
AI summary · may contain errors
Atorvastatin promotes bone anabolism under estrogen-deficient conditions by driving osteogenic differentiation of LEPR+ bone marrow stromal cells, including skeletal stem/progenitor cells.
- Open access
AI summary · may contain errors
In 25 ER-positive breast cancer patients, single-cell profiling links high ER signaling and ER-bound enhancer activity to sensitivity to neoadjuvant aromatase inhibitors.
- Open access
AI summary · may contain errors
ERα loss-of-function in rat right ventricular endothelial cells reduces angiogenic behaviors and worsens RV capillary density, with stronger effects in females (e.g., 10 and 28 days).
- Open access
- 1 cites
AI summary · may contain errors
Menopause is a midlife neuroendocrine transition linked to women’s brain aging and Alzheimer’s disease vulnerability, with timing and hormone changes shaping neurobiological risk.
AI summary · may contain errors
Long-term tamoxifen exposure in endometrial tumors shifts ERα binding away from PR-shared sites, increasing ERα occupancy at PR-independent regions enriched for ERE motifs.
- Open access
AI summary · may contain errors
17β-estradiol treatment after ovariectomy is linked to reduced atherosclerosis in young female Ldlr-/- mice, but fails in older mice, where it promotes inflammatory, vulnerable plaque features.
- Open access
AI summary · may contain errors
Hepatic estrogen receptor α is proposed to shape sex-biased partitioning of muscle-derived branched-chain amino acid carbon and amino nitrogen among oxidation, lipid synthesis, recycling, and disposal in MASLD susceptibility.
- Open access
AI summary · may contain errors
SERDs, including fulvestrant and newer oral agents like elacestrant and imlunestrant, are linked to increased antitumor immunity in breast cancer, beyond their hormone-blocking effects.
- Open access
AI summary · may contain errors
ESR1-L536 mutations in ER-positive metastatic breast tumors are linked to reduced elacestrant benefit, with longer hazard and shorter time-on-treatment (HR=2.089, p=0.001).
- Open access
AI summary · may contain errors
Estradiol and testosterone are linked to longitudinal cerebellar volume change in aging adults, with direction and significance differing by sex across specific Crus I/II and Lobule regions.
- Open access
AI summary · may contain errors
Circulating endotrophin levels are higher in estrogen receptor-positive, HER2-negative breast cancer than in triple-negative disease, with median 35.98 vs 19.67 ng/mL.
- Open access
AI summary · may contain errors
In premenopausal hormone receptor-positive early breast cancer, 15-year breast cancer-free interval is highest with exemestane plus ovarian function suppression (78.6%) versus tamoxifen plus OFS (75.7%) and tamoxifen alone (72.1%).
- Open access
- 6 cites
AI summary · may contain errors
Invasive lobular carcinoma remains understudied in systemic therapy evidence, leaving its E-cadherin loss, diffuse growth, and metastatic tropism underrepresented in histology-agnostic trials.
- Open access
AI summary · may contain errors
Menopause is linked to metabolomic changes—especially in lipoproteins and metabolites like lipids, fatty acids, and amino acids—that are associated with a more atherogenic profile and, in some cases, higher cardiovascular disease risk.
- Open access
Browse JClub
Journals this month
- bioRxiv6412
- medRxiv1763
- PNAS556
- JAMA353
- Sci Adv330
- Cell Rep315
- Environ Res225
- BMJ217
- EHJ206
- Nat Commun172
- NAR172
- Plant Cell Environ167
- Environ Pollution153
- Science152
- Curr Biol148
- NEJM148
- New Phytol147
- Nature128
Topics moving, week to 17 Nov 2026
- Single-cell and spatial transcriptomics10
- Gut microbiota and health6
- CAR-T cell therapy research6
- Pancreatic and Hepatic Oncology Research5
- Genomics and Chromatin Dynamics5
- Inflammatory Bowel Disease5
- Lung Cancer Treatments and Mutations5
- Antibiotic Resistance in Bacteria5
- Genomics and Phylogenetic Studies4
- Lipoproteins and Cardiovascular Health4
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
